CG
ABBV icon

Clarus Group’s AbbVie ABBV Stock Holding History

Clarus Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$518K Buy
2,057
+6
+0.3% +$1.29K 0.18% 53
2026
Q1 		$446K Sell
2,051
-181
-8% -$40.1K 0.16% 56
2025
Q4 		$510K Buy
2,232
+5
+0.2% +$1.14K 0.18% 51
2025
Q3 		$516K Buy
2,227
+5
+0.2% +$1.02K 0.18% 55
2025
Q2 		$412K Buy
2,222
+6
+0.3% +$1.11K 0.15% 61
2025
Q1 		$464K Buy
2,216
+44
+2% +$8.55K 0.18% 54
2024
Q4 		$386K Sell
2,172
-447
-17% -$82.2K 0.14% 69
2024
Q3 		$517K Sell
2,619
-133
-5% -$24.8K 0.22% 50
2024
Q2 		$472K Sell
2,752
-742
-21% -$123K 0.21% 62
2024
Q1 		$636K Buy
3,494
+7
+0.2% +$1.21K 0.45% 39
2023
Q4 		$540K Sell
3,487
-490
-12% -$71.4K 0.41% 46
2023
Q3 		$593K Sell
3,977
-269
-6% -$39.5K 0.43% 46
2023
Q2 		$572K Buy
4,246
+491
+13% +$72K 0.42% 39
2023
Q1 		$598K Buy
3,755
+106
+3% +$16.2K 0.56% 28
2022
Q4 		$590K Sell
3,649
-554
-13% -$84.9K 0.52% 32
2022
Q3 		$564K Buy
4,203
+6
+0.1% +$861 0.51% 32
2022
Q2 		$643K Buy
4,197
+6
+0.1% +$917 0.54% 31
2022
Q1 		$679K Sell
4,191
-92
-2% -$13.4K 0.46% 33
2021
Q4 		$494K Buy
4,283
+8
+0.2% +$945 0.33% 44
2021
Q3 		$461K Sell
4,275
-40
-0.9% -$4.57K 0.32% 45
2021
Q2 		$503K Sell
4,315
-100
-2% -$11.3K 0.38% 40
2021
Q1 		$465K Buy
4,415
+565
+15% +$60.4K 0.39% 44
2020
Q4 		$402K Buy
+3,850
New +$370K 0.35% 50

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Clarus Group's ABBV Position: Q2 2026 in Review

Clarus Group increased its AbbVie (ABBV) stake by 0.29% in Q2 2026, buying an estimated $1.29K and bringing the position to 2,057 shares worth $518K. The position accounts for 0.18% of the portfolio, ranked #53.

Clarus Group first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $679K in Q1 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Clarus Group held 2,057 shares of AbbVie worth $518K as of Q2 2026.
  • Clarus Group bought 6 AbbVie shares in Q2 2026, an estimated $1.29K.
  • AbbVie made up 0.18% of Clarus Group's portfolio in Q2 2026, its #53 holding.
  • Clarus Group first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Clarus Group's AbbVie position peaked at $679K in Q1 2022.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Clarus Group's 13F filing for Q2 2026, filed 24 Jul 2026.